Review Of The Drug Enforcement Administration's (DEA)
Control Of The Diversion Of Controlled Pharmaceuticals

Report Number I-2002-010
September 2002


TABLE OF CONTENTS

MEMORANDUM

EXECUTIVE SUMMARY

INTRODUCTION

BACKGROUND

RESULTS OF THE INSPECTION

CONCLUSION

APPENDIX I—Diversion Investigator work years for all types of investigations, 1993-2001 - [Not available electronically]

APPENDIX II—Diversion Investigator and Special Agent work years for controlled pharmaceutical and illicit drug investigations, 1993-2001

APPENDIX III—Percentage of time spent by Diversion Investigators on all types of investigations, 1993-2001 - [Not available electronically]

APPENDIX IV—DEA Management Response

APPENDIX V—Office of the Inspector General's Analysis of the DEA's Management Response